Quality of Life Among Children and Adolescents With Cancer
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This descriptive study aims to allow children and adolescents who have cancer to self-evaluate their quality of life. It is hypothesized that treatment affects quality of life in the areas of physical and social functioning. It is further hypothesized that these effects dissipate within 6 months after treatment is completed.
| Condition |
|---|
|
Cancer |
| Study Type: | Observational |
| Study Design: | Time Perspective: Cross-Sectional |
| Official Title: | Quality of Life Among Children and Adolescents With Cancer |
| Estimated Enrollment: | 75 |
| Study Start Date: | March 2005 |
| Estimated Study Completion Date: | March 2005 |
Study participants will include all children and adolescents (aged 7 to 21 years old) currently receiving care from the Hematology/Oncology Clinic at the CMHC, which will serve as the study site. These individuals will be identified by the health care professionals working in the clinic. Specific study criteria will include only those individuals who (1) can read or write in the English language (due to limited availability of translators); (2) appear to not possibly suffer psychological harm by participating (as determined by any health care professional working in the Clinic); and (3) do not have a health condition and/or medical need that supersedes study participation. The weekly list of appointments will be reviewed by the researchers who already work in the Clinic for appropriateness (JH, JB and KS). To prevent participation coercion, solicitation for participation will be provided through the Child Life Specialist (CLS). The CLS is known to each participant and will function as a data collector for this study.
Eligibility| Ages Eligible for Study: | 9 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:Study participants will include all children and adolescents (aged 7 to 21 years old) currently receiving care from the Hematology/Oncology Clinic at the CMHC, which will serve as the study site. These individuals will be identified by the health care professionals working in the clinic. Specific study criteria will include only those individuals who (1) can read or write in the English language (due to limited availability of translators); (2) appear to not possibly suffer psychological harm by participating (as determined by any health care professional working in the Clinic); and (3) do not have a health condition and/or medical need that supersedes study participation. -
Exclusion Criteria: (1) Those electing not to participate; (2) those with no guardian available to consent or (3) those not yet diagnosed with a cancer condition.
-
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00285363
| United States, Missouri | |
| Children's Mercy Hospitals and Clinics | |
| Kansas City, Missouri, United States, 64108 | |
| Principal Investigator: | Peggy Ward-Smith, PhD | University of Missouri, Kansas City |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00285363 History of Changes |
| Other Study ID Numbers: | 04 05-052E, CMCC grant |
| Study First Received: | January 31, 2006 |
| Last Updated: | January 31, 2006 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Children's Mercy Hospital Kansas City:
|
cancer quality of life adolescents |
ClinicalTrials.gov processed this record on February 27, 2015